1 Min Read
Sept 1 (Reuters) - Adherium Ltd
* Adherium receives U.S. 510(k) clearance for next generation smartinhaler for Astrazeneca’s Symbicort aerosol inhaler Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.